Understanding the composition of the TME will also benefit in the research of a potential systemic therapeutic approach not only for patients suffering from VS, who are not suitable for surgery due to age, comorbidity, or size of the tumor, but even more importantly for patients suffering from NF2. The gene discussed is NF2; the disease is neoplasm.